Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection
| Autor: | Zohreh Erfani, Mohammad Hassan Zahedroozegar, Amirhossein Salimi, Farzaneh Mohammadi, Mohammad Javad Ashraf, Maryam Salimi, Hesan Jelodari Mamaghani, Kianoush Niknam, Mohammad Reza Sasani, Zeinab Mehrabi |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Antifungal
Pediatrics medicine.medical_specialty Past medical history Coronavirus disease 2019 (COVID-19) business.industry medicine.drug_class Mucormycosis Case Report General Medicine Case presentation RE1-994 After discharge medicine.disease Ophthalmology Corticosteroid therapy Pandemic medicine business |
| Zdroj: | Case Reports in Ophthalmological Medicine Case Reports in Ophthalmological Medicine, Vol 2021 (2021) |
| ISSN: | 2090-6730 2090-6722 |
| DOI: | 10.1155/2021/9745701 |
| Popis: | Background. Mucormycosis is a rare and invasive fungal infection, affecting almost exclusively immunocompromised individuals. Immunosuppressive effects of corticosteroids which are widely prescribed in COVID-19 patients might be a predisposing factor for opportunistic infections even though the other factors should also be considered. Case Presentation. A middle-aged man without any significant past medical history was admitted to the hospital due to a severe COVID-19 infection. He received a high dose of corticosteroids as a part of the treatment. Five days after discharge, he presents with a headache and fever. Eventually, orbital mucormycosis was diagnosed for him and he was treated with antifungal medications. Conclusion. Opportunistic infections should be considered during the current pandemic of COVID-19, during which corticosteroids are widely prescribed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|